• Home
  • About the initiative
  • Rare Cancer Types
  • Contact us
  • Publications
  • Home
  • About the initiative
  • Rare Cancer Types
  • Contact us
  • Publications

Publications

Lancet Oncology (48.5 KB)

International Rare Cancers Initiative (IRCI)

Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers Initiative

Abstracts and Posters

  • International Rare Cancers Initiative (577 KB)
  • ASCO Meeting Library
  • International Rare Cancers Initiative on the NCRI Cancer Conference website

cruk-logo3

cruk-logo3

eortc-logo3

eortc-logo3

inca-logo3

inca-logo3

nci-logo3

nci-logo3

ncic-logo2

ncic-logo2

nhs-logo3

nhs-logo3
  • Sitemap
  • Privacy
  • Cookies
  • Terms & Conditions
  • Accessibility

The International Rare Cancers Initiative is a joint initiative between Cancer Research UK, the National Institute of Health Research Clinical Research Network, the National Cancer Institute, the European Organisation for Research and Treatment of Cancer, the Institut National Du Cancer and the National Cancer Institute of Canada Clinical Trial Group. The Initiative is administrated from Cancer Research UK.
Cancer Research UK is a registered charity in England and Wales (1089464), Scotland (SC041666) and the Isle of Man (1103). A company limited by guarantee. Registered company in England and Wales (4325234) and the Isle of Man (5713F).